Markets:

Overview

News

Currencies

International

Treasuries

Altamira Therapeutics Ltd. - Common Shares (NQ:CYTO)

0.3001 UNCHANGED

Last Price Updated: 3:55 PM EST, Dec 19, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Altamira Therapeutics Ltd. - Common Shares

< Previous 1 2 3 4 5 6 7 8 9 Next >

Clinical Study Demonstrates Bentrio's Superior Nasal Residence Time and Rheological Properties

March 03, 2023

Via ACCESSWIRE

Altamira Therapeutics Files Provisional Patent Application for OligoPhore Nanoparticles Targeting Different KRAS Mutations in Cancer Treatment

February 27, 2023

From Altamira Therapeutics Ltd

Via GlobeNewswire

Altamira Therapeutics to Report Bentrio Clinical Data, in House Dust Mite and Grass Pollen Allergic Rhinitis, at Feb. 25 AAAAI Annual Meet-ing

February 14, 2023

Via ACCESSWIRE

Altamira Therapeutics to Present at Two Upcoming RNA Therapeutics Conferences in Q1 2023

February 07, 2023

Via ACCESSWIRE

Dow Gains Over 100 Points; Eastern Bankshares Shares Drop After Q4 Results ↗

January 27, 2023

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 1% on Friday. The Dow traded up 0.41% to 34,088.68 while the NASDAQ rose 1.27% to 11,659.16. The S&P 500...

Via Benzinga

Why Applied UV Shares Are Trading Higher By 46%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

January 27, 2023

Gainers FOXO Technologies Inc. (NYSE: FOXO) shares jumped 109% to $1.07. Akanda Corp. (NASDAQ: AKAN) rose 59% to $0.4459 after jumping 47% on Thursday.

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

January 27, 2023

During Friday, 24 stocks hit new 52-week lows.

Via Benzinga

US Stocks Higher; Dow Rises 150 Points ↗

January 27, 2023

U.S. stocks traded higher this morning, with the Dow Jones gaining over 50 points on Friday. Following the market opening Friday, the Dow traded up 0.47% to 34,107.87 while the NASDAQ rose 0.55% to...

Via Benzinga

Altamira Therapeutics Provides Business Update

January 27, 2023

From Altamira Therapeutics Ltd

Via GlobeNewswire

Dow Rises 80 Points; Altamira Therapeutics Shares Plunge ↗

January 24, 2023

U.S. stocks traded mixed toward the end of trading, with the Dow Jones gaining around 80 points on Tuesday. The Dow traded up 0.24% to 33,710.06 while the NASDAQ fell 0.21% to 11,340.24. The S&P 500...

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

January 24, 2023

During Tuesday, 17 stocks hit new 52-week lows.

Via Benzinga

Why Baudax Bio Shares Are Trading Higher By 60%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

January 24, 2023

Gainers Baudax Bio, Inc. (NASDAQ: BXRX) shares surged 59.7% to $5.03 after the company announced the outcome of its first interim analysis in a Phase II trial of BX1000 for neuromuscular blockade in...

Via Benzinga

Dow Drops 100 Points; Verizon Issues Weak Earnings Forecast ↗

January 24, 2023

U.S. stocks traded lower this morning, with the Dow Jones dropping more than 100 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.31% to 33,524.12 while the NASDAQ fell...

Via Benzinga

Altamira Therapeutics Provides Update on Clinical Trials with Bentrio

January 24, 2023

From Altamira Therapeutics Ltd

Via GlobeNewswire

Altamira Therapeutics to Present at 2nd Annual mRNA-Based Therapeutics Summit Europe Conference January 24th to 26th

January 10, 2023

From Altamira Therapeutics Ltd

Via GlobeNewswire

Altamira Therapeutics Provides Year-End 2022 Business Update

December 19, 2022

From Altamira Therapeutics Ltd

Via GlobeNewswire

Altamira Therapeutics Reaches Midpoint for Enrollment in Clinical Trial with Bentrio in Seasonal Allergic Rhinitis in Australia

December 02, 2022

Via ACCESSWIRE

Altamira Therapeutics Provides Business Update and First Half 2022 Financial Results

November 30, 2022

From Altamira Therapeutics Ltd

Via GlobeNewswire

Altamira Therapeutics Announces Launch of Bentrio in Hong Kong by its Partner Nuance Pharma

November 30, 2022

From Altamira Therapeutics Ltd

Via GlobeNewswire

In Vivo Data Presented at AHA Conference Demonstrates Altamira Therapeutics' SemaPhore mRNA Delivery Platform to Effectively Help Preserve Atherosclerotic Plaque Stability

November 22, 2022

Via ACCESSWIRE

Altamira Therapeutics to Participate at TIDES Europe Oligonucleotide and Peptide Therapeutics Hybrid Event

November 10, 2022

From Altamira Therapeutics Ltd

Via GlobeNewswire

Altamira Therapeutics Regains Listing Compliance with NASDAQ Minimum Bid Requirement

November 09, 2022

From Altamira Therapeutics Ltd

Via GlobeNewswire

Data Published in Peer-Reviewed Journal Demonstrate Protective Effects of Altamira’s Bentrio under Controlled Grass Pollen Exposure

November 08, 2022

From Altamira Therapeutics Ltd

Via GlobeNewswire

Altamira Therapeutics Announces Reverse Stock Split

October 24, 2022

From Altamira Therapeutics Ltd

Via GlobeNewswire

Why Tricida Shares Dipped Around 95%; Here Are 73 Biggest Movers From Yesterday ↗

October 25, 2022

Gainers Applied Genetic Technologies Corporation (NASDAQ: AGTC) climbed 62.4% to close at $0.39. Syncona disclosed that it will acquire Applied Genetic Technologies Corporation.

Via Benzinga

Dow Jumps 650 Points; Gold Rises Over 1% ↗

October 21, 2022

U.S. stocks traded higher toward the end of trading, with the Dow Jones jumping around 650 points on Friday.

Via Benzinga

Why Huntington Bancshares Shares Surged Around 10%; Here Are 72 Biggest Movers From Friday ↗

October 24, 2022

Gainers Huadi International Group Co., Ltd. (NASDAQ: HUDI) jumped 89.3% to close at $58.92 on Friday.

Via Benzinga

Nasdaq Surges 150 Points; Snap Shares Plunge ↗

October 21, 2022

U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 500 points on Friday.

Via Benzinga

Why Boston Beer Shares Are Trading Higher? Here Are 52 Stocks Moving In Friday's Mid-Day Session ↗

October 21, 2022

Gainers Altamira Therapeutics Ltd. (NASDAQ: CYTO) surged 67% to $0.5484 after the company announced divestiture of its inner ear development assets.

Via Benzinga

Why Are Big Tech Stocks Down Today? ↗

October 21, 2022

Big tech stocks aren't doing so hot on Friday and it looks like traders have Snap's (SNAP) Q3 earnings to blame for the fall.

Via InvestorPlace

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.